SKYLUMYS Trademark

Trademark Overview

On Tuesday, September 3, 2019, a trademark application was filed for SKYLUMYS with the United States Patent and Trademark Office. The USPTO has given the SKYLUMYS trademark a serial number of 88601907. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 9, 2023. This trademark is owned by Reata Pharmaceuticals, Inc.. The SKYLUMYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, mitochondrial diseases, seizure disorders, and neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuromuscular, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy; none of the foregoing including pharmaceutical preparations for the treatment of pain
skylumys

General Information

Serial Number88601907
Word MarkSKYLUMYS
Filing DateTuesday, September 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 9, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological diseases and disorders, namely, mitochondrial diseases, seizure disorders, and neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuromuscular, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy; none of the foregoing including pharmaceutical preparations for the treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReata Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrving, TX 75063
Party NameReata Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75063

Trademark Events

Event DateEvent Description
Tuesday, October 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 9, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 24, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 6, 2023SOU EXTENSION 5 GRANTED
Tuesday, February 21, 2023SOU EXTENSION 5 FILED
Monday, March 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2022SOU EXTENSION 4 GRANTED
Wednesday, July 27, 2022SOU EXTENSION 4 FILED
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 1, 2022SOU EXTENSION 3 GRANTED
Tuesday, March 1, 2022SOU EXTENSION 3 FILED
Tuesday, March 1, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 24, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 24, 2021SOU EXTENSION 2 FILED
Tuesday, August 24, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 2, 2021SOU EXTENSION 1 GRANTED
Tuesday, March 2, 2021SOU EXTENSION 1 FILED
Tuesday, March 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 30, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, July 30, 2020ASSIGNED TO PETITION STAFF
Thursday, July 16, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 23, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, February 4, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 5, 2019ASSIGNED TO EXAMINER
Friday, September 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 6, 2019NEW APPLICATION ENTERED

Related Keywords

skylumys disorders preparations pharmaceutical diseases treatment mitochondrial none epilepsy including pain